Clinical trial NCT01344122: Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)
Official title: Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Opioid-Related Disorders
Alcohol-Related Disorders
Lead sponsor: Rhode Island Hospital
Sponsor class: OTHER
Collaborators: name: Arizona State University
name: Friends Research Institute, Inc.
name: National Development and Research Institutes, Inc.
name: National Institute on Drug Abuse (NIDA)
name: Temple University
name: Texas Christian University
name: University of California, Los Angeles
name: University of Connecticut
name: University of Delaware
name: University of Kentucky
name: University of Puerto Rico
First posted: 2011-04-28
Enrollment: 20
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL

Brief summary: The goal of this study is to see whether or not a strategic planning process is able to introduce and sustain improvements in the working relationship between probation/parole departments and community-based addiction treatment agencies that provide medication assisted therapy (MAT) for individuals with opioid or alcohol dependence. In addition, this study seeks to improve probation/parole agency personnel's knowledge and perceptions about MAT, and increase the number of appropriate referrals to community treatment agencies that provide MAT. There are three phases to this study. Phase 1 includes a pilot study to determine the quality and availability of client level records and the collection of baseline data (the pilot study protocol was previously submitted to TMH IRB). Phase 2 will consist of a Knowledge, Perceptions and Information (KPI) intervention during which probation/parole agencies will undergo training to increase knowledge about the effectiveness of MAT, and complete a post training assessment to evaluate the effectiveness of the KPI intervention. During Phase 3, probation/parole agencies will be randomly assigned to a 12-month Organizational Linkage Intervention (OLI) condition or to control (no further intervention). Agencies assigned to the OLI will establish a Pharmacotherapy Exchange Council (PEC) that consists of staff from both the probation/parole and community treatment agencies. The PEC will undergo a strategic planning process to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole.


Eligibility criteria: Probation/parole or community treatment agency staff.

Primary outcomes:
measure: Opinions About MAT
timeFrame: 6-month follow-up
Secondary outcomes:
measure: Interorganizational Relationships
timeFrame: 6-month follow-up
measure: Referrals to Medication Assisted Treatment (MAT)
timeFrame: 6-Month Follow-up
Other outcomes:
Locations:
Study officials:
affiliation: Rhode Island Hospital
name: Peter D Friedmann, MD, MPH
role: PRINCIPAL_INVESTIGATOR
References:
citation: Friedmann PD, Wilson D, Knudsen HK, Ducharme LJ, Welsh WN, Frisman L, Knight K, Lin HJ, James A, Albizu-Garcia CE, Pankow J, Hall EA, Urbine TF, Abdel-Salam S, Duvall JL, Vocci FJ. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. J Subst Abuse Treat. 2015 Mar;50:50-8. doi: 10.1016/j.jsat.2014.10.001. Epub 2014 Oct 14.